528 related articles for article (PubMed ID: 25393773)
1. The diagnostic performance of cardiac magnetic resonance in detection of myocardial involvement in AL amyloidosis.
Fikrle M; Palecek T; Masek M; Kuchynka P; Straub J; Spicka I; Rysava R; Linhart A
Clin Physiol Funct Imaging; 2016 May; 36(3):218-24. PubMed ID: 25393773
[TBL] [Abstract][Full Text] [Related]
2. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
[TBL] [Abstract][Full Text] [Related]
3. Myocardial deformation imaging by two-dimensional speckle-tracking echocardiography for prediction of global and segmental functional changes after acute myocardial infarction: a comparison with late gadolinium enhancement cardiac magnetic resonance.
Altiok E; Tiemann S; Becker M; Koos R; Zwicker C; Schroeder J; Kraemer N; Schoth F; Adam D; Friedman Z; Marx N; Hoffmann R
J Am Soc Echocardiogr; 2014 Mar; 27(3):249-57. PubMed ID: 24368027
[TBL] [Abstract][Full Text] [Related]
4. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis.
Ternacle J; Bodez D; Guellich A; Audureau E; Rappeneau S; Lim P; Radu C; Guendouz S; Couetil JP; Benhaiem N; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Mohty D; Deux JF; Damy T
JACC Cardiovasc Imaging; 2016 Feb; 9(2):126-38. PubMed ID: 26777222
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular magnetic resonance in cardiac amyloidosis.
Maceira AM; Joshi J; Prasad SK; Moon JC; Perugini E; Harding I; Sheppard MN; Poole-Wilson PA; Hawkins PN; Pennell DJ
Circulation; 2005 Jan; 111(2):186-93. PubMed ID: 15630027
[TBL] [Abstract][Full Text] [Related]
6. LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis.
Boynton SJ; Geske JB; Dispenzieri A; Syed IS; Hanson TJ; Grogan M; Araoz PA
JACC Cardiovasc Imaging; 2016 Jun; 9(6):680-6. PubMed ID: 27209101
[TBL] [Abstract][Full Text] [Related]
7. Left Ventricular Myocardial Deformation on Cine MR Images: Relationship to Severity of Disease and Prognosis in Light-Chain Amyloidosis.
Wan K; Sun J; Yang D; Liu H; Wang J; Cheng W; Zhang Q; Zeng Z; Zhang T; Greiser A; Jolly MP; Han Y; Chen Y
Radiology; 2018 Jul; 288(1):73-80. PubMed ID: 29664336
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
Mohty D; Boulogne C; Magne J; Varroud-Vial N; Martin S; Ettaif H; Fadel BM; Bridoux F; Aboyans V; Damy T; Jaccard A
Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):961-9. PubMed ID: 27194782
[TBL] [Abstract][Full Text] [Related]
9. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.
Mark PB; Johnston N; Groenning BA; Foster JE; Blyth KG; Martin TN; Steedman T; Dargie HJ; Jardine AG
Kidney Int; 2006 May; 69(10):1839-45. PubMed ID: 16508657
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Prognostic Value of Cardiac Magnetic Resonance in Left Ventricle Noncompaction: A Prospective Multicenter Study.
Andreini D; Pontone G; Bogaert J; Roghi A; Barison A; Schwitter J; Mushtaq S; Vovas G; Sormani P; Aquaro GD; Monney P; Segurini C; Guglielmo M; Conte E; Fusini L; Dello Russo A; Lombardi M; Gripari P; Baggiano A; Fiorentini C; Lombardi F; Bartorelli AL; Pepi M; Masci PG
J Am Coll Cardiol; 2016 Nov; 68(20):2166-2181. PubMed ID: 27855806
[TBL] [Abstract][Full Text] [Related]
11. Comparison of echocardiographic parameters in Fabry cardiomyopathy and light-chain cardiac amyloidosis.
Marek J; Palecek T; Magne J; Lavergne D; Boulogne C; Fadel BM; Jaccard A; Linhart A; Mohty D
Echocardiography; 2018 Nov; 35(11):1755-1763. PubMed ID: 30247786
[TBL] [Abstract][Full Text] [Related]
12. CMR-based differentiation of AL and ATTR cardiac amyloidosis.
Dungu JN; Valencia O; Pinney JH; Gibbs SD; Rowczenio D; Gilbertson JA; Lachmann HJ; Wechalekar A; Gillmore JD; Whelan CJ; Hawkins PN; Anderson LJ
JACC Cardiovasc Imaging; 2014 Feb; 7(2):133-42. PubMed ID: 24412186
[TBL] [Abstract][Full Text] [Related]
13. Potential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis.
Dohy Z; Szabo L; Pozsonyi Z; Csecs I; Toth A; Suhai FI; Czimbalmos C; Szucs A; Kiss AR; Becker D; Merkely B; Vago H
PLoS One; 2022; 17(6):e0269807. PubMed ID: 35696411
[TBL] [Abstract][Full Text] [Related]
14. Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging.
Barison A; Aquaro GD; Pugliese NR; Cappelli F; Chiappino S; Vergaro G; Mirizzi G; Todiere G; Passino C; Masci PG; Perfetto F; Emdin M
J Intern Med; 2015 May; 277(5):605-14. PubMed ID: 25346163
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study.
Chatzantonis G; Bietenbeck M; Elsanhoury A; Tschöpe C; Pieske B; Tauscher G; Vietheer J; Shomanova Z; Mahrholdt H; Rolf A; Kelle S; Yilmaz A
Clin Res Cardiol; 2021 Apr; 110(4):555-568. PubMed ID: 33170349
[TBL] [Abstract][Full Text] [Related]
16. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
[TBL] [Abstract][Full Text] [Related]
17. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
[TBL] [Abstract][Full Text] [Related]
18. Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation.
Ling LH; Taylor AJ; Ellims AH; Iles LM; McLellan AJ; Lee G; Kumar S; Lee G; Teh A; Medi C; Kaye DM; Kalman JM; Kistler PM
Heart Rhythm; 2013 Sep; 10(9):1334-9. PubMed ID: 23811081
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of systolic and diastolic function in patients with LGE negative systemic amyloidosis using CMR.
Kuetting DL; Homsi R; Sprinkart AM; Luetkens J; Thomas DK; Schild HH; Dabir D
Int J Cardiol; 2017 Apr; 232():336-341. PubMed ID: 28153537
[TBL] [Abstract][Full Text] [Related]
20. Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.
Hashimura H; Ishibashi-Ueda H; Yonemoto Y; Ohta-Ogo K; Matsuyama TA; Ikeda Y; Morita Y; Yamada N; Yasui H; Naito H
Heart Vessels; 2016 Jun; 31(6):990-5. PubMed ID: 25794983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
